Matthew Lumley
Amministratore Delegato presso Myosana Therapeutics, Inc.
Posizioni attive di Matthew Lumley
Società | Posizione | Inizio | Fine |
---|---|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investitore di Private Equity | 01/01/2023 | - |
Myosana Therapeutics, Inc.
Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Amministratore Delegato | 01/11/2021 | - |
Direttore/Membro del Consiglio | 01/11/2021 | - |
Storia della carriera di Matthew Lumley
Formazione di Matthew Lumley
King's College London | Doctorate Degree |
Imperial College London | Undergraduate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 4 |
Stati Uniti | 2 |
Posizioni
Private Equity Investor | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Finance |
Myosana Therapeutics, Inc.
Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Matthew Lumley
- Esperienza